– Small amounts of pathogenic mitochondria may get carried over during pronuclear transfer,observed at varying levels (up to 16%) across some children.
– Potential health risks could emerge over time or across tissues,prompting calls for close monitoring.
This development marks a significant milestone in tackling hereditary diseases caused by dysfunctional mitochondria while sparking ethical and regulatory debates worldwide. For India-a country with growing expertise and initiatives in genomic medicine-this advancement underscores the importance of creating robust regulatory frameworks around emerging reproductive technologies. as similar techniques gain ground globally,potential lessons lie for India concerning public engagement on ethical concerns and ensuring accessibility through safe clinical practices.
Monitoring over time will be essential as this breakthrough raises questions regarding long-term efficacy against disease transmission and challenges like residual pathogenic mitochondria affecting future generations. Adopting such cutting-edge innovation responsibly could expand avenues for healthier families but demands caution to minimize unforeseen medical complications.